Dove Keith Brenden-Colson Canter for Pancreatic Care Oregon Health & Science University Biography Publications Institution JoVE Articles Dove Keith has not added a biography. If you are Dove Keith and would like to personalize this page please email our Author Liaison for assistance. Publications Accessible High-throughput Single-cell Whole-genome Sequencing with Paired Chromatin Accessibility Cell Reports Methods. Nov, 2023 | Pubmed ID: 37918402 Deletion of the MRNA Stability Factor (HuR) in Pancreatic Cancer Cells Disrupts the Tumor Microenvironment Integrity NAR Cancer. Jun, 2023 | Pubmed ID: 37089813 Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer Without Increasing Perioperative Complications Cancers. Jan, 2022 | Pubmed ID: 35158877 Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic Adenocarcinoma JCO Precision Oncology. 2021 | Pubmed ID: 34036232 Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome Cancer Discovery. Aug, 2021 | Pubmed ID: 33727309 Melittin Initiates Dopamine Transporter Internalization and Recycling in Transfected HEK-293 Cells European Journal of Pharmacology. Sep, 2012 | Pubmed ID: 22683840 Melittin Stimulates Fatty Acid Release Through Non-phospholipase-mediated Mechanisms and Interacts with the Dopamine Transporter and Other Membrane-spanning Proteins European Journal of Pharmacology. Jan, 2011 | Pubmed ID: 20969853 Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets Amani Alshaikh1,2, Dmytro Grygoryev3, Dove Keith4, Brett Sheppard4,5, Rosalie C Sears4,6, Jungsun Kim3,6, Abdenour Soufi1 1Centre for Regenerative Medicine, Institute of Regeneration and Repair, Institute of Stem Cell Research, The University of Edinburgh, 2King Abdulaziz City for Science and Technology Health Sector (KACST), 3Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, 4Brenden-Colson Canter for Pancreatic Care, Oregon Health & Science University, 5Department of Surgery, Oregon Health & Science University, 6Department of Molecular & Medical Genetics, Oregon Health & Science University JoVE 65811 Recherche en cancérologie
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets Amani Alshaikh1,2, Dmytro Grygoryev3, Dove Keith4, Brett Sheppard4,5, Rosalie C Sears4,6, Jungsun Kim3,6, Abdenour Soufi1 1Centre for Regenerative Medicine, Institute of Regeneration and Repair, Institute of Stem Cell Research, The University of Edinburgh, 2King Abdulaziz City for Science and Technology Health Sector (KACST), 3Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, 4Brenden-Colson Canter for Pancreatic Care, Oregon Health & Science University, 5Department of Surgery, Oregon Health & Science University, 6Department of Molecular & Medical Genetics, Oregon Health & Science University JoVE 65811 Recherche en cancérologie